Search Press releases Keywords From To 12 Nov 2014 Transparency notification of Vanguard Health Care Fund Read More 7 Nov 2014 UCB to sell its U.S. specialty generics business Kremers Urban to Advent International and Avista Capital Partners for US$ 1,525 million Read More 28 Oct 2014 UCB enhances epilepsy presence in Japan and China: positive Phase 3 study for VIMPAT® Read More 24 Oct 2014 UCB Interim Report for the first nine months of 2014: UCB continues the growth path Read More 23 Sep 2014 Acquisition of own shares Read More 16 Sep 2014 New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density Read More Pagination First page Previous page Previous … Page 101 Page 102 Page 103 Page 104 Current page 105 Page 106 Page 107 Page 108 Page 109 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
